0001728411-22-000004.txt : 20220824 0001728411-22-000004.hdr.sgml : 20220824 20220823175958 ACCESSION NUMBER: 0001728411-22-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220823 EFFECTIVENESS DATE: 20220824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DMC Biotechnologies, Inc. CENTRAL INDEX KEY: 0001728411 IRS NUMBER: 471479674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456800 FILM NUMBER: 221188479 BUSINESS ADDRESS: STREET 1: 2477 55TH STREET, SUITE 120 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-239-7239 MAIL ADDRESS: STREET 1: 2477 55TH STREET, SUITE 120 CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0708 D LIVE 0001728411 DMC Biotechnologies, Inc. 2477 55TH STREET, SUITE 120 BOULDER CO COLORADO 80301 720-239-7239 DELAWARE None None Corporation true Matthew Lipscomb c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Executive Officer Director Michael D. Lynch c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Carolyn Fritz c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Rob van der Meij c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Josko Bobanovic c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Doug Cameron c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Alastair Cooper c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Ashley Jenkins c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Executive Officer Biotechnology Decline to Disclose 06b false 2022-08-11 false true true false 0 66720 66720 0 The Total Offering Amount and Total Amount Sold represent the aggregate exercise price of a warrant to purchase shares of capital stock of the Issuer. false 1 0 0 0 false DMC Biotechnologies, Inc. /s/ Matthew Lipscomb Matthew Lipscomb Chief Executive Officer 2022-08-19